System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Britt K Erickson, MD

Gynecology — University of Minnesota, United States

LeadR Profile

Britt K Erickson, MD University of Minnesota United States
753 ScienceLeadR Reputation 753

Unlock

Register Login
Network Map

Gynecology

Subspecialties: Oncology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026
Source: PubMed

University of Minnesota

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 147

Citations

Citations: 18 661 1st author: 22 Last author: 26 Unique author: 31

Main journals

Gynecol Oncol 28
Chem Eng News 19
Anal Chem 9
J Low Genit Tract Dis 8
Gynecol Oncol Rep 7

Best Journals

N Engl J Med 7
J Clin Oncol 6
BMJ 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
An analysis of the readability of Gynecologic Cancer patient education materials.
reading, ovary, genital neoplasms, female, neoplasms, education, patient education as topic		Gynecol Oncol20260
Primary pelvic extraskeletal Ewing sarcoma: a case report and comprehensive literature review of molecularly confirmed cases arising within the female genital tract.
urinary bladder, genes, sarcoma, ewing, genitalia, female, uterus, sarcoma, diagnosis, vagina		Gynecol Oncol Rep20260
Oophorectomy-Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity.
mortality, incidence, ovary, neoplasms, ovarian neoplasms, fallopian tubes, ovariectomy		Cancer Med20260
Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249.
lymph node excision, genital neoplasms, female, neoplasms, classification, genes, p53, therapeutics		Gynecol Oncol20260
Genomic and transcriptomic differences between neuroendocrine neoplasms and carcinomas with human papillomavirus (HPV).
neoplasms, viruses, alphapapillomavirus, human papillomavirus viruses		Infect Agent Cancer20260

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 3 8
Phase 2 2
Early Phase 1 1
N/A 1

By status:

Completed 9
Active not recruiting 2
Recruiting 1

By type:

Interventional 12

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 1
multicentricup10 7

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild Type Advanced or Recurrent Endometrial Carcinoma
NCT05611931 — administration, oral, neoplasms, dosage forms, tablets, maintenance, response evaluation criteria in solid tumors, therapeutics, endometrial neoplasms, carcinoma		Phase 3Active not recruiting2023
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
NCT05256225 — taxes, cells, research design, blood, adenocarcinoma, clear cell, paclitaxel, radionuclide angiography, tomography, brachytherapy, neoplasms, adenocarcinoma, gated blood-pool imaging, angiography, drug therapy, echocardiography, carcinosarcoma, specimen handling, therapeutics, carboplatin, radionuclide ventriculography, trastuzumab, endometrial neoplasms, hyaluronoglucosaminidase, chemotherapy, carcinoma		Phase 3Active not recruiting2022
Study of Carboplatin and Mirvetuximab Soravtansine in First Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced Stage Ovarian Fallopian Tube or Primary Peritoneal Cancer
NCT04606914 — cells, genes, lung, pharmaceutical preparations, disulfides, fallopian tube neoplasms, ovary, neoplasms, carcinoma, non-small-cell lung, bevacizumab, biopsy, drug therapy, carcinoma, renal cell, phosphatidylinositols, glycosylphosphatidylinositols, maintenance, maytansine, lung neoplasms, ovarian neoplasms, small cell lung carcinoma, physicians, antibodies, monoclonal, peritoneal neoplasms, therapeutics, tissues, carboplatin, folate receptor 1, carcinoma, ovarian epithelial, fallopian tubes, endometrial neoplasms, chemotherapy		Phase 2Recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS